Randall, M D <br/><br/>
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation.  [electronic resource] 

 -  European journal of pharmacology  Sep 1997 
 - 205-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0014-2999 
<br/><br/><label>Standard No.: </label>10.1016/s0014-2999(97)01237-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Arachidonic Acids--pharmacology<br/>Biological Factors--antagonists & inhibitors<br/>Bradykinin--pharmacology<br/>Calcium Channel Blockers--pharmacology<br/>Cannabinoid Receptor Modulators<br/>Cannabinoids--antagonists & inhibitors<br/>Clotrimazole--pharmacology<br/>Coronary Vessels--drug effects<br/>Endocannabinoids<br/>In Vitro Techniques<br/>Male<br/>Muscle, Smooth, Vascular--drug effects<br/>Piperidines--pharmacology<br/>Polyunsaturated Alkamides<br/>Potassium Channel Blockers<br/>Pyrazoles--pharmacology<br/>Quaternary Ammonium Compounds--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Receptors, Cannabinoid<br/>Receptors, Drug--antagonists & inhibitors<br/>Rimonabant<br/>Vasodilation--drug effects